Biofourmis
Sarah Sossong is an accomplished professional with extensive experience in strategic engagement within the health sector. Currently serving as a Mentor at CancerX and Techstars Boston Accelerator, Sossong also holds the position of Principal at ARENΛ since January 2015, where responsibilities include advancing commercial strategy and partnerships for various health-related organizations. Additional roles include advising at Redesign Health and Scalable Care, serving on the steering committee of Ignite Health, and acting as an Angel Investor for Portfolia. Sossong previously held the position of Director of Commercial Strategy at DexCare and has a background in executive roles at a stealth startup. Sossong's educational credentials include a Bachelor of Arts from Princeton University and a Master of Public Health from the University of California, Berkeley, along with a certificate in Finance & Accounting from Columbia Business School.
This person is not in any teams
This person is not in any offices
Biofourmis
6 followers
Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. They are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain.